147 related articles for article (PubMed ID: 24441243)
1. Nodular lymphocyte predominant Hodgkin lymphoma and diphenylhydantoin: report of a case and review of the literature.
Sharma S; Menon H; Sengar M; Gujral S
Indian J Pathol Microbiol; 2013; 56(4):440-2. PubMed ID: 24441243
[TBL] [Abstract][Full Text] [Related]
2. A case of composite classical and nodular lymphocyte predominant Hodgkin lymphoma with progression to diffuse large B-cell non-Hodgkin lymphoma: Diagnostic difficulty in fine-needle aspiration cytology.
Das DK; Sheikh ZA; Al-Shama'a MH; John B; Alawi AM; Junaid TA
Diagn Cytopathol; 2017 Mar; 45(3):262-266. PubMed ID: 27888658
[TBL] [Abstract][Full Text] [Related]
3. A high number of IgG4-positive plasma cells rules out nodular lymphocyte predominant Hodgkin lymphoma.
Kiil K; Bein J; Schuhmacher B; Thurner L; Schneider M; Hansmann ML; Hartmann S
Virchows Arch; 2018 Dec; 473(6):759-764. PubMed ID: 30259184
[TBL] [Abstract][Full Text] [Related]
4. Relapsed nodular lymphocyte-predominant Hodgkin lymphoma presenting as severe paraneoplastic hepatitis: a case report.
Deacon AJ; Goetz NN; Weber N; Clouston A; Gonsalkorala E; Baskerville C; Leggett B
J Med Case Rep; 2023 Jun; 17(1):269. PubMed ID: 37386640
[TBL] [Abstract][Full Text] [Related]
5. Diphenylhydantoin-induced hepatitis: a case report.
Gloria L; Serejo F; Cruz E; Freitas J; Costa A; Ramalho F; Batista A; de Moura MC
Hepatogastroenterology; 1998; 45(20):411-4. PubMed ID: 9638415
[TBL] [Abstract][Full Text] [Related]
6. Does functional imaging distinguish nodular lymphocyte-predominant hodgkin lymphoma from T-cell/histiocyte-rich large B-cell lymphoma?
Barber NA; Loberiza FR; Perry AM; Bast M; Holdeman KP; Esfahane AB; Weisenburger DD; Vose J; Bierman P; Armitage JO; Bociek RG
Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):392-7. PubMed ID: 23773450
[TBL] [Abstract][Full Text] [Related]
7. [Lymphadenopathy in phenytoin treatment (author's transl)].
Seyfeddinipur N
Dtsch Med Wochenschr; 1976 Oct; 101(40):1454-6. PubMed ID: 823005
[TBL] [Abstract][Full Text] [Related]
8. Lymphoproliferative disorders in four patients receiving chronic diphenylhydantoin therapy: etiologic correlation or chance association?
Matzner Y; Polliack A
Isr J Med Sci; 1978 Aug; 14(8):865-9. PubMed ID: 700999
[TBL] [Abstract][Full Text] [Related]
9. Intranodular clusters of activated cells with T follicular helper phenotype in nodular lymphocyte predominant Hodgkin lymphoma: a pilot study of 32 cases from Finland.
Nathwani BN; Vornanen M; Winkelmann R; Kansal R; Doering C; Hartmann S; Hansmann ML
Hum Pathol; 2013 Sep; 44(9):1737-46. PubMed ID: 23684509
[TBL] [Abstract][Full Text] [Related]
10. Intraparotid classical and nodular lymphocyte-predominant Hodgkin lymphoma: pattern analysis with emphasis on associated lymphadenoma-like proliferations.
Agaimy A; Wild V; Märkl B; Wachter DL; Hartmann A; Rosenwald A; Ihrler S
Am J Surg Pathol; 2015 Sep; 39(9):1206-12. PubMed ID: 25929348
[TBL] [Abstract][Full Text] [Related]
11. Localized cervical lymphadenopathy induced by diphenylhydantoin sodium.
Greene DA
Arch Otolaryngol; 1975 Jul; 101(7):446-8. PubMed ID: 807190
[TBL] [Abstract][Full Text] [Related]
12. Plasma-cell type Castleman's disease of the neck and lymphocyte-depletion Hodgkin lymphoma associated with intestinal intussusception in an AIDS patient.
Lai CH; Tsai JW; Lin JN; Hsieh PM; Lin HH
J Microbiol Immunol Infect; 2013 Jun; 46(3):234-6. PubMed ID: 22503801
[TBL] [Abstract][Full Text] [Related]
13. Nodular Lymphocyte-Predominant Hodgkin Lymphoma in a Warthin Tumor of the Parotid Gland: A Case Report and Literature Review.
Di Napoli A; Mallel G; Bartolazzi A; Cavalieri E; Becelli R; Cippitelli C; Ruco L
Int J Surg Pathol; 2015 Aug; 23(5):419-23. PubMed ID: 26169920
[TBL] [Abstract][Full Text] [Related]
14. Lymphadenopathy in children.
Bedros AA; Mann JP
Adv Pediatr; 1981; 28():341-76. PubMed ID: 7041562
[No Abstract] [Full Text] [Related]
15. A Rare Case of Good Outcome of Hodgkin Lymphoma in a Patient with HIV on Antiretroviral Therapy (ART).
Abidoye O; Ogbuagu H; Varghese M
Am J Case Rep; 2022 May; 23():e936267. PubMed ID: 35568967
[TBL] [Abstract][Full Text] [Related]
16. Malignant lymphoma after diphenylhydantoin (dilantin) therapy.
Li FP; Willard DR; Goodman R; Vawter G
Cancer; 1975 Oct; 36(4):1359-62. PubMed ID: 1175133
[TBL] [Abstract][Full Text] [Related]
17. Modern management of lymphocyte-predominant Hodgkin lymphoma.
Xing KH; Savage KJ
Br J Haematol; 2013 May; 161(3):316-29. PubMed ID: 23398605
[TBL] [Abstract][Full Text] [Related]
18. Immunoarchitectural patterns in nodular lymphocyte predominant Hodgkin lymphoma: pathologic and clinical implications.
Gloghini A; Bosco A; Ponzoni M; Spina M; Carbone A
Expert Rev Hematol; 2015 Apr; 8(2):217-23. PubMed ID: 25487651
[TBL] [Abstract][Full Text] [Related]
19. Primary Extranodal Nodular Lymphocyte Predominant Hodgkin Lymphoma Involving the Thyroid.
Williams TP; Raess PW; Braziel R; Cascio MJ
Head Neck Pathol; 2020 Jun; 14(2):550-553. PubMed ID: 31292857
[TBL] [Abstract][Full Text] [Related]
20. [Hodgkin's disease following treatment with hydantoins. Report of a case and review of the literature (author's transl)].
Bladé Creixenti J; Segura Porta F; Nogué Xarau S; Soriano Marín E; García San Miguel J
Med Clin (Barc); 1980 Jun; 75(1):24-6. PubMed ID: 7392707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
